Your browser doesn't support javascript.
loading
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer.
Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I; Melear, Jason M; Chung, Ki Y; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I.
Afiliación
  • Plummer R; Newcastle University and Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom. Electronic address: Ruth.Plummer@newcastle.ac.uk.
  • Dean E; The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: Emma.Dean@doctors.org.uk.
  • Arkenau HT; Sarah Cannon Research Institute, London, United Kingdom. Electronic address: Tobias.Arkenau@hcahealthcare.co.uk.
  • Redfern C; Sharp Healthcare, San Diego, CA, United States.
  • Spira AI; Virginia Cancer Specialists Research Institute and US Oncology Research, Fairfax, VA, United States.
  • Melear JM; Texas Oncology, Austin, TX, United States. Electronic address: Jason.Melear@usoncology.com.
  • Chung KY; Prisma Health, Greenville, SC, United States. Electronic address: Ki.Chung@prismahealth.org.
  • Ferrer-Playan J; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Goddemeier T; Merck Healthcare KGaA, Darmstadt, Germany.
  • Locatelli G; Merck Healthcare KGaA, Darmstadt, Germany.
  • Dong J; EMD Serono Research & Development Institute, Inc., Billerica, MA, United States.
  • Fleuranceau-Morel P; EMD Serono Research & Development Institute, Inc., Billerica, MA, United States.
  • Diaz-Padilla I; Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States. Electronic address: Geoffrey_Shapiro@dfci.harvard.edu.
Lung Cancer ; 163: 19-26, 2022 01.
Article en En | MEDLINE | ID: mdl-34894455
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article